Jennie Sterning

Chief Financial Officer

Finansinspektionen (Sweden) Files from Sweden

Compiled from cited public records — every figure names the disclosure it came from, none copied from any wealth ranking. How we calculate this.

Issuers on file
2
issuers named in insider transaction reports filed to Finansinspektionen (FI) in Sweden

Not measurable for this profile: Reconstructed positions · 1-day change

Trading activity Jun 13, 2017 – Nov 13, 2018

Jennie Sterning reported 13 transactions between Jun 13, 2017 and Nov 13, 2018. The buy and sell totals below count only code SACQ.

Open-market buys (SACQ)
322.5K SEK
9 purchases on file priced rows only
Open-market sales
None
0 sales on file
All reported transactions
13
every code, including awards and exercises
Pattern
No transaction in the final 12 months of the window
last 12 months of the window

Reported transactions

Price 0.00 is a real reported figure on allotments, gifts and option exercises — not a missing number. The 13 most recent rows are grouped into 9 lines by date, company and transaction type — open a line to see every lot with its own source link.

How to read this list

Every row is one insider transaction as reported to FI, with a link back to the FI register filtered to that issuer and publication date. FI publishes no per-report permalink, so the link is a search, not a document. Where the record carries no price at all we leave the cell empty instead of guessing one.

The shares and money on a grouped line add up only the lots listed inside that line, and only when every one of them carries the figure. Where a group mixes more than one reporting currency we leave the money blank rather than convert — no source publishes the rate that conversion would need.

  1. EQL Pharma AB SSUB Subscription × 2not a buy/sell decision 16,478 shares 98.9K SEK
    The 2 lots that make up this line, each with the source behind it.
    Shares Price Value Filing
    13,650 6.00 SEK 81.9K SEK FI filing ↗
    2,828 6.00 SEK 17.0K SEK FI filing ↗
  2. EQL Pharma AB SEXD Exercise decrease × 2not a buy/sell decisionreported at zero 98,868 shares 0 SEK
    The 2 lots that make up this line, each with the source behind it.
    Shares Price Value Filing
    81,900 0.00 SEKreported at zero 0 SEK FI filing ↗
    16,968 0.00 SEKreported at zero 0 SEK FI filing ↗
  3. EQL Pharma AB SACQ Acquisition × 2 48,960 shares 20.3K SEK
    The 2 lots that make up this line, each with the source behind it.
    Shares Price Value Filing
    20,000 0.42 SEK 8.4K SEK FI filing ↗
    28,960 0.41 SEK 11.9K SEK FI filing ↗
  4. EQL Pharma AB SACQ Acquisition 16,240 shares 7.5K SEK at 0.46 SEK FI filing ↗
  5. EQL Pharma AB SACQ Acquisition 6,181 shares 54.1K SEK at 8.75 SEK FI filing ↗
  6. EQL Pharma AB SACQ Acquisition 6,000 shares 52.8K SEK at 8.80 SEK FI filing ↗
  7. EQL Pharma AB SACQ Acquisition × 2 10,527 shares 92.6K SEK
    The 2 lots that make up this line, each with the source behind it.
    Shares Price Value Filing
    5,700 8.80 SEK 50.2K SEK FI filing ↗
    4,827 8.80 SEK 42.5K SEK FI filing ↗
  8. EQL Pharma AB SACQ Acquisition 5,000 shares 44.8K SEK at 8.95 SEK FI filing ↗
  9. Eqlpharma Ak SACQ Acquisition 5,700 shares 50.5K SEK at 8.86 SEK FI filing ↗

Reconstructed positions

We hold no share-level ownership disclosure naming Jennie Sterning. Anything this person is known to own appears in the stated-assets section above, quoted and attributed — we do not estimate what is missing.

Sources

Every figure on this page is quoted from the public record named beside it, with the date it was true. Nothing here is our own calculation.

Think a number here is wrong? Check the named disclosure and its date against the tables above — how to report it.

Profile record last refreshed Sep 14, 2026.